QEEG-guided neurofeedback for recurrent migraine headaches.
ABSTRACT Seventy-one patients with recurrent migraine headaches, aged 17-62, from one neurological practice, completed a quantitative electroencephalogram (QEEG) procedure. All QEEG results indicated an excess of high-frequency beta activity (21-30 Hz) in 1-4 cortical areas. Forty-six of the 71 patients selected neurofeedback training while the remaining 25 chose to continue on drug therapy. Neurofeedback protocols consisted of reducing 21-30 Hz activity and increasing 10 Hz activity (5 sessions for each affected site). All the patients were classified as migraine without aura. For the neurofeedback group the majority (54%) experienced complete cessation of their migraines, and many others (39%) experienced a reduction in migraine frequency of greater than 50%. Four percent experienced a decrease in headache frequency of < 50%. Only one patient did not experience a reduction in headache frequency. The control group of subjects who chose to continue drug therapy as opposed to neurofeedback experienced no change in headache frequency (68%), a reduction of less than 50% (20%), or a reduction greater than 50% (8%). QEEG-guided neurofeedback appears to be dramatically effective in abolishing or significantly reducing headache frequency in patients with recurrent migraine.
SourceAvailable from: ocean.kisti.re.kr[Show abstract] [Hide abstract]
ABSTRACT: The purpose of this study was to identify the effects of Neurofeedback(NF), Cranio-Sacral Therapy(CST) and Combine Therapy(CT) in middle aged women through their experiences after participating these therapies. The participants were 53 middle aged women who lived in S city, 17 in the NF group, 17 in the CST and 19 in the CT, for 10 weeks from October to December, 2007. The NF group had 30 sessions, the CST group had 10 sessions and the CT group had 30 sessions of NF training after 10 sessions of CST. The data was collected from daily chart by self reporting their experiences during sessions. Collected data was analyzed by content analysis. From raw data, 37 items of NF, 91 items of CST and 110 items of CT were extracted in the content analysis. Similar items were gathered to 22 attributes of NF, 63 of CST and 68 of CT. These attributes were categorized into 9 higher attributes. The dominant attributes of NF were doziness during the training, mental comfort, lightening of physical and mental condition. Mental and physical comfort, improvement of sleep, healthy condition, crying were the dominant of CST. Also mental and physical comfort, lightening of physical condition, improvement of sleep, tear were the dominant of CT. According to the results of this study NF, CST and CT were very effective on physical and psychological relaxation. Therefore it is recommended that these NF, CST and CT be used as a complementary and alternative medicine(CAM) in middle aged women.03/2012; 13(3). DOI:10.5762/KAIS.2012.13.3.1042
[Show abstract] [Hide abstract]
ABSTRACT: Headache is one of the most prevalent investigated complaints in the neurology clinics and is the most common pain-related complaint worldwide. Stress is a significant factor that causes and triggers headaches. Since healthcare practitioners experience a lot of stress in their careers, they are more prone to headaches.08/2014; 16(8):e17799. DOI:10.5812/ircmj.17799
[Show abstract] [Hide abstract]
ABSTRACT: Neurofeedback (NF) is gaining recognition as an evidence-based intervention grounded in learning theory, and 19-channel z-score NF (19ZNF) is a new NF model. This pilot study sought to evaluate the efficacy of 19ZNF in a clinical setting. Outcome measures framed groups such that 19ZNF was evaluated, as it relates to the neuropsychological constructs of attention (n = 10), executive function (n = 12), behavior (n = 14), and electrocortical functioning (n = 21). One-tailed t tests compared pre-post difference scores. For all pre-post comparisons, the direction of change was in the predicted direction, and differences were statistically significant (p = .000 to p = .008, effect sizes 1.29 to 3.42). Results suggest 19ZNF improved attention, executive function, behavior, and electrocortical function. This study provides beginning evidence of 19ZNF's efficacy, adds to what is known about 19ZNF, and offers an innovative approach for using quantitative electroencephalographic (QEEG) metrics as outcome measures. © 2015 SAGE Publications.Journal of Attention Disorders 03/2015; DOI:10.1177/1087054715577135 · 2.40 Impact Factor